In development: A range of orally disintegrating strips (ODS) that offer an alternative to conventional oral formulations such as those in liquid or pill form. ODS has the ability to dissolve rapidly without water, providing an alternative to patients who are unable to swallow or suffering from nausea, such as those receiving chemotherapy. Due to the ease of administration, this results in better patient compliance and accurate dosing of the drugs. Clinical trials have been conducted and our manufacturing facility has recently been approved by the Pharmaceutical Inspection Co-operation Scheme (PIC/S).